Defining chromosomal instability
|
|
- Myles Hardy
- 5 years ago
- Views:
Transcription
1 Opinion Defining chromosomal instability Jochen B. Geigl, Anna C. Obenauf, Thomas Schwarzbraun and Michael R. Speicher Institute of Human Genetics, Medical University of Graz, A-8010 Graz, Austria Most scientists agree that the majority of human solid malignant tumors are characterized by chromosomal instability (CIN) involving gain or loss of whole chromosomes or fractions of chromosomes. CIN is thought to be an early event during tumorigenesis and might therefore be involved in tumor initiation. Despite its frequent occurrence in tumors and its potential importance in tumor evolution, CIN is poorly defined and is used inconsistently and imprecisely. Here, we provide criteria to define CIN and argue that few experimental approaches are capable of assessing the presence of CIN. Accurate assessment of CIN is crucial to elucidate whether CIN is a driving force for tumorigenesis and whether a chromosomally unstable genome is necessary for tumor progression. Genomic instability in malignant solid tumors Molecular biology has unequivocally shown that tumors accumulate numerous mutated genes [1]. Underlying genomic instability might accelerate the accumulation of these mutations. Many theories regarding the timing and the impact of genomic instability (see Glossary) in cancer, such as the mutator phenotype [2], telomere dysfunction [3] or the aneuploidy hypothesis [4], have been proposed [5]. Among the most intriguing questions in this context are the following. (i) Does genomic instability represent an early or late event in tumor progression? (ii) Is genomic instability the driving force for tumorigenesis? (iii) Is an unstable genome necessary for tumor evolution? [6,7]. Among different forms of inherent genomic instability (Box 1), chromosomal instability (CIN) is the most prevalent form [8]. Despite the possible importance of CIN for tumor initiation and progression, it is surprising that CIN is poorly defined and that the use of CIN is frequently inconsistent and imprecise. For example, CIN is used to describe cancers that are shown, by cytogenetics or flow cytometry, to have an aneuploid or polyploid karyotype. It has also been used to describe cells that harbor multiple structural chromosomal rearrangements. Others describe CIN as frequent alterations in chromosome number [8 16]. Here we provide a definition for the widely used term CIN, define how it can be distinguished from genomic instability, aneuploidy and polyploidy and assess the suitability of current methods for the detection of CIN. The clarification of the type of chromosomal condition that is referred to by CIN and how CIN should be properly investigated and measured could contribute to the better assessment and treatment of CIN in pre-cancerous and early-stage lesions. For a discussion of the significance of Corresponding author: Speicher, M.R. (michael.speicher@meduni-graz.at). unstable chromosomes in cancer and the mechanisms that might promote CIN, see Refs. [6,7,9,17 19]. Genomic versus chromosomal instability The vast majority of malignant diseases have some underlying form of instability [9]. Genomic instability refers to various instability phenotypes, including the CIN phenotype. Currently, instability phenotypes are best characterized for colorectal cancer (Box 1). Here, instability is subdivided into CIN and microsatellite instability (MIN or MSI) [8,9]; their occurrence is usually mutually exclusive in colorectal cancer cell lines [20]. The MIN phenotype occurs in 15% of all tumors and is often not associated with chromosomal changes [21]. A third of these cases (5% of all colorectal cancers) are associated with a family history of colorectal cancers and are often caused by mutations in mismatch repair genes [i.e. human MutS homolog 2 (hmsh2), human MutL homolog 1 (hmlh1), human MutS homolog 6 (hmsh6), and human postmeiotic segregation increased 2 (hpms2)], Glossary Aneuploidy: Having an unbalanced number of chromosomes or large portions of chromosomes. An alteration in the number of intact chromosomes is termed whole-chromosome aneuploidy. Segmental aneuploidies refer to unbalanced regions of chromosomes, e.g. caused by deletions, amplifications or translocations. Chromosomal instability (CIN): As described in the text, a poorly defined but often used expression. CIN should describe the rate (cell-to-cell variability) of gain or loss of whole chromosomes or fractions of chromosomes. This definition encompasses the rate of both whole-chromosome and segmental chromosomal aneuploidies. Comparative genomic hybridization (CGH): A technology through which a test and reference DNA sample are differentially labeled to identify copy number changes in the respective test genome. In conventional CGH, both test and reference DNAs are hybridized to metaphase spreads. To improve resolution, the DNAs are now hybridized to immobilized DNA targets on an appropriate surface, referred to as array-cgh. CpG island methylator phenotype (CIMP): The CIMP phenotype is characterized by extensive promotor methylation, methylation of MLH1 and a strong association with the V600E mutation in BRAF; CIMP cells are chromosomally stable but exhibit MIN. Genomic instability: Genomic instability includes CIN but also refers to other forms of presently known genomic instabilities, such as microsatellite instability (MIN) or CIMP. In addition, other, yet unknown, forms of instabilities might exist. Loss of heterozygosity (LOH): LOH in a cell represents the loss of one parent s contribution to a portion of the cell s genome and is the result of a genomic change, such as mitotic deletion, gene conversion or chromosome missegregation. Microsatellite instability (MIN or MSI): In diploid tumors, genetic instability that results from a high mutation rate, primarily in short nucleotide repeats. Cancers with the MIN (or MSI) phenotype are associated with defects in DNAmismatch-repair genes. Multiplex-FISH (M-FISH) or spectral karyotyping (SKY): Techniques for painting each chromosome of an organism in a different color, which is useful for deciphering numerical and structural chromosomal aberrations. Polyploidy: A polyploid cell has more than two sets of chromosomes (two sets being the prevalent diploid state). A tetraploid cell has four sets of chromosomes, an octaploid has eight sets, and so on /$ see front matter ß 2007 Elsevier Ltd. All rights reserved. doi: /j.tig Available online 14 January
2 Box 1. Genomic instability phenotypes in colorectal cancer Chromosomal instability (CIN): occurs in 80 85% of all colorectal cancers [8,9]. Microsatellite instability (MIN or MSI): associated with a germline mutation in a mismatch repair gene (i.e. MLH1, MSH2, MSH6 and PMS2) causing hereditary nonpolyposis colorectal cancer (HNPCC); occurs in 5% of all colorectal cancers [21]. Sporadic MIN: in most cases, this phenotype overlaps with the CpG island methylator phenotype (CIMP) and is found in most tumors with mutations in the BRAF oncogene; occurs in 10% of all colorectal cancers [22,23]. Potentially other, presently not yet identified, forms of instabilities: some tumors display no signs of MIN, CIMP, or CIN [26]. Thus, a subset of tumors without any instability might exist, or these tumors exhibit a new form of instability that has not yet been identified. Large-scale sequencing efforts might have the potential to elucidate such a putative new form of instability. resulting in hereditary nonpolyposis colorectal cancer (HNPCC) [21]. About two thirds of MIN-tumors occur sporadically, and these tumors usually have a V600E substitution in B-Raf [22]. Recent findings have shown that most cases of sporadic MIN overlap with the CpG island methylator phenotype (CIMP), which is characterized by extensive promotor methylation [23]. The available data indicate that the CIN phenotype is the most common instability phenotype, occurring in 80 85% of all colorectal cancers [8]. The classical pathway of colorectal tumorigenesis resulting in CIN(+), MIN( ) and CIMP( ) tumors involves the initiation of an adenomatous polyp through bi-allelic adenomatous polyposis coli (APC) mutations. The affected polyps become progressively larger and more dysplastic, often acquiring mutations in KRAS, a potent oncogene, and SMAD4 (SMAD4 participates in cell signaling); loss of heterozygosity (LOH) and a mutation in the tumor suppressor gene TP53, by which stage the polyp has become an early carcinoma [24,25]. Genomic instability might occur at some point during the process of tumorigenesis. Intriguingly, some colorectal cancers display none of these instability phenotypes (i.e. CIN, MIN or CIMP) [26], and it is not known whether they have acquired a different form of genomic instability. Aneuploidy and polyploidy versus chromosomal instability In principle, there are two ways for cells to become aneuploid: they can develop alterations in the number of intact chromosomes, which is known as whole chromosome aneuploidy and originates from errors in cell division (mitosis). Alternatively, chromosomal rearrangements can occur, including deletions, amplifications or translocations, which arise from breaks in DNA and result in segmental aneuploidy. Segmental aneuploidy is a well-established cause of tumor development. For example, telomere dysfunction and inactivated checkpoints can, through fusion-bridgebreakage cycles, result in unbalanced, nonreciprocal translocations, i.e. segmental aneuploids [3]. By contrast, the contribution of whole chromosome aneuploidy to cancer is controversial [17]. Some mouse models for spindle assembly checkpoint failure associated with chromosome number instability show early aging-associated phenotypes without an increased predisposition to spontaneous tumor development [18,27,28], whereas other mouse models support the idea that aneuploidy might promote oncogenesis [29,30]. The best evidence in favor of a causative role for a spindle checkpoint gene in tumorigenesis is the discovery that inherited mutations in budding uninhibited by benzimidazoles 1 (BUB1B) result in chromosomal segregation defects and increased tumor incidence in humans [31]. However, aneuploidy is not synonymous with CIN; this point is best exemplified by humans with Down syndrome (DS). The majority of cases of DS are associated with a trisomy 21 in all cells [32]. However, because each cell harbors the same chromosomal composition without any variation, humans with DS do not have CIN, although each cell is aneuploid. Therefore, CIN should not be equated with aneuploidy. One might argue that the stable aneuploidy in DS cells facilitates the onset of cancer and CIN because epidemiologic data indicate that trisomy 21 predisposes patients to leukemia, especially acute megakaryoblastic leukemia (AMKL) [33]. However, gene dosage alterations caused by the trisomy 21 alone do not seem to be sufficient to cause AMKL, because current transformation models suggest that somatic mutations are also required in the X-chromosome gene, GATA-binding protein 1 (GATA1), which encodes an essential transcriptional regulator of normal megakaryocytic differentiation [33]. Furthermore, although the risk for leukemia is increased in individuals with DS, solid tumors of childhood and adult nonhematologic cancers are significantly less frequent [34,35], suggesting that the trisomy 21 constitution does not, in general, predispose patients to malignant diseases or CIN. The same considerations are also true for polyploidy: the presence of triploid or tetraploid chromosome constitutions by itself does not make a cell population unstable. The differences between aneuploidy, polyploidy and CIN can be further clarified by considering the cell-to-cell variability, the state and the rate of chromosomal changes. Cell-to-cell variability, state and rate of chromosomal changes The existence of genetic alterations in a tumor, even when frequent, does not necessarily indicate that the tumor is genetically unstable. For example, if a tumor is analyzed by comparative genomic hybridization (CGH) using DNA extracted from a large cell population, it is likely that several gains and losses will be identified [36]. Such gains and losses provide evidence for chromosomal rearrangements that might be extensive and complex. However, chromosomal imbalances observed by CGH do not enable conclusions to be drawn about the instability pattern, because the observed gains and losses could be the result of a stable, but aneuploid, clone that has obtained a growth advantage under certain selective pressures. Thus, an array-cgh profile describes a state of chromosomal alterations; therefore, the presence of multiple gains or losses within a tumor genome cannot be equated with CIN. Instead, the presence of CIN can be more reliably assessed by measurements of the cell-to-cell variability, which provides a good indicator for CIN but does not accurately 65
3 measure the rate of chromosome number alterations. Strictly, the determination of rate requires time-based measurements, which could establish how frequently the karyotypes of sister or daughter cells are not identical to each other or to their mother cells. Such rate experiments are feasible in cell culture experiments [8,9]; however, it is nearly impossible to perform such analyses on tissue samples obtained by surgery or fine needle biopsies. In summary, the rate of chromosomal changes indicates the degree of cell-to-cell variability, and this rate might differ significantly within a cell population with CIN. CIN-high versus CIN-low It is common practice to stratify MSI as either MSI-high or MSI-low depending on the number of markers that have microsatellite alterations [37 39]; similarly, there are CIN-high and CIN-low phenotypes [40,41]. It was suggested that severe deficiencies for proteins involved in DNA damage sensing and DNA repair pathways might accelerate aging, whereas less severe mutations in these same pathways might predispose individuals to cancer [19]. By analogy, one could argue that the aging phenotype in some mouse CIN models could be explained through a similar pattern. Therefore, CIN-low (i.e. a low rate of cellto-cell variability), rather than CIN-high (i.e. a high rate of cell-to-cell variability), phenotypes might be important for cancer initiation. However, the identification of cells displaying the CIN-low phenotype probably requires particularly sensitive methods, such as the evaluation of very large cell numbers and assays providing full karyotypic information. Methods for the analysis of CIN The imprecise use of the term CIN is also a result of the inappropriate methods used to address the presence of CIN. Determination of CIN requires approaches capable of monitoring cell-to-cell variability or the rate of chromosomal changes. Analyses of the timing of CIN and the detection of the kinds of chromosome alterations likely to be present in early tumors is further hampered by the small size of samples and the possibility that chromosomal aberrations might not yet be present in most cells. For these challenging analyses, several methods exist, each with different strengths and weaknesses (Table 1). Single cell approaches The key strength of single cell approaches is their ability to perform analyses on a cell per cell basis, whereas the molecular or multiple cell methods are performed on a merged population of cells in which chromosomal instability is often masked. Interphase fluorescence in situ hybridization (FISH) enables the rapid screening of hundreds of cells and provides cellular chromosomal copy numbers for the regions included in the respective probe set [36]. Especially popular are chromosome-specific centromere probes, because their use usually results in signals with high fluorescence intensities, thus facilitating evaluation. Additional or missing chromosome-specific centromere signals are usually interpreted as evidence for whole chromosome aneuploidy [8,10 15]. By contrast, regionspecific probes are used to assess the presence of selected regions on chromosome arms. A missing signal might indicate either segmental aneuploidy or whole chromosome aneuploidy; probe sets can be tailored to distinguish between them [36]. For example, if probes for both the long and short chromosome arms (p- and q-arms) are applied and both probes simultaneously have a reduced or an increased signal, loss or gain of the entire respective chromosome is likely. The disadvantage of interphase FISH is that only a limited number of probes can be used simultaneously. Thus, chromosomal copy number changes could be missed. Karyotyping, either by traditional banding analysis or by 24-color FISH [i.e. multiplex FISH or spectral karyotyping (SKY)], yields information about chromosomal copy numbers, chromosomal structural changes and cell-to-cell variability [36]. However, the preparation of metaphase spreads from solid tumors is labor intensive and requires skilled multidisciplinary teams including surgeons, pathologists and cytogeneticists. Furthermore, metaphase spreads from even short-term cultures might acquire culturing artifacts, which can mask characteristics of the tumor. Lagging chromosomes or chromosome fragments can be excluded from the main daughter nuclei during cell division and form small nuclei within the cytoplasm; these are termed micronuclei. Thus, the presence of micronuclei is a surrogate marker for CIN; unlike other approaches, this detection method is based on cell morphology without direct visualization of chromosomes or genomic regions. Micronuclei counting is a very popular method of CIN analysis because it enables the rapid evaluation of hundreds of cells [15,16]. However, it cannot distinguish whole chromosome aneuploidy from segmental aneuploidy. By contrast, array-cgh easily identifies both whole chromosome and segmental aneuploidies [36]. Recently developed protocols for the isolation of individual cells and unbiased whole genome amplification enable these analyses to be performed using DNA derived from as little as a single cell [42,43]. Therefore, single cell array-cgh currently offers the best resolution for the assessment of CIN and the presence of whole chromosome or segmental aneuploidies. However, single cell array-cgh is not amenable to automation and therefore does not represent a highthroughput approach. Multiple cell approaches Several cytogenetic and molecular techniques are available that use a multiple cell approach (Table 1). Although these technologies are extremely valuable for the detection of aneuploidies, they allow, at best, only indirect conclusions to be drawn regarding the presence of chromosomal instability. Conventional array-cgh usually uses DNA from multiple cells and therefore describes the state, rather than cell-to-cell variability, or the rate, of chromosomal changes in a tumor. However, array-cgh offers the opportunity to detect and evaluate low-level mosaicisms within populations containing as few as 10 20% abnormal cells [44]. Because of this ability, it should be possible to estimate whether chromosomal imbalances are present in all cells or in just a subset. 66
4 Table 1. Current methods for the assessment of chromosomal changes in solid tumors a,b Method Chromosomal change detected Cell-to-cell variability (rate) c State c Interphase-FISH with centromere probes WCA Interphase-FISH with chromosome arm/region-specific probes WCA and SA Karyotyping (banding analysis/24-color karyotyping) WCA and SA Micronuclei counting WCA and SA cannot be distinguished Single cell-array CGH WCA and SA Conventional array-cgh (DNA extracted from multiple cells) WCA and SA Digital PCR Allelic imbalance as a surrogate for SA ++ 1 Flow cytometry WCA and SA cannot be distinguished Loss of heterozygosity SA SNP-array WCA, SA, LOH and LOH without copy number change a FISH, fluorescence in situ hybridization; WCA, whole chromosome aneuploidy; SA, segmental aneuploidy; CGH, comparative genomic hybridization; LOH, loss of heterozygosity. b The first five rows indicate single-cell approaches; the last five rows indicate multiple cell approaches. c The usefulness for assessing the cell-to-cell variability or the rate of chromosomal changes (which best indicates chromosomal instability) and the state of chromosomal alterations (which does not provide accurate data about a possible instability) is outlined in the following rating scale: +++, best currently available approach; ++, less suitable, however, still provides valuable information; +, reveals, at best, some indirect information. 1, unsuitable. Digital polymerase chain reaction (PCR) or digital single nucleotide polymorphism (SNP) analysis is a PCR-based approach in which the alleles within a tumor sample are individually counted [45]. Digital PCR identifies allelic imbalances, which reflect gains and losses of particular chromosomal regions. The presence of allelic imbalances has been used as a marker for CIN in earlystage tumors [46]. Flow cytometry efficiently allows the identification of the relative nuclear DNA content and ploidy level of many cells. A flow cytometer measures cells in suspension that flow in single file through an illuminated volume where they scatter light and emit fluorescence; the intensity of the fluorescence correlates with the DNA content. All cells that have equal quantities of the cellular content being measured (e.g. DNA) form a defined peak. Similarly, cells with increased or decreased DNA content because of aneuploidy are visible as additional peaks. However, flow cytometry does not provide reliable information about cell-to-cell variability; moreover, the presence of cells with different ploidy levels does not necessarily indicate CIN. In cancer, LOH is identified by the presence of heterozygosity at a genetic locus in an organism s germline DNA and the absence of heterozygosity at the locus in the cancer cells. LOH can arise by several pathways, including deletion, gene conversion, mitotic recombination and chromosome loss. Because LOH analysis is performed using DNA from multiple cells, it describes a state but not a rate of variability. In recent years, analyses that use SNP arrays have become popular because they offer the unique opportunity to detect, simultaneously, DNA copy number changes and LOH [47]. The hybridization of single cell amplification products to SNP arrays has not been reported, however, implying that this array-platform is not yet suitable for the estimation of CIN. Important criteria for a CIN definition Many published results reporting CIN describe the state, rather than the cell-to-cell variability or the rate, of chromosomal changes. However, CIN is not synonymous with the state of aneuploidy that is observed in a static image of the chromosomal content of a cancer cell. Therefore, several parameters should be included in a description of chromosomal changes to determine the presence of CIN. Because CIN refers to the rate with which whole chromosomes or large portions of chromosomes are gained or lost in cancers, the rate should be described as cell-to-cell variability or variability between cell populations. The rate of chromosomal changes in a test cell population should be compared with a reference cell population. This comparison will be especially important in the detection of the CIN-low phenotype. To achieve accurate quantification, the number of cell divisions that a population has undergone should be related to the rate of chromosomal change. An optimal CIN assay should reliably measure not only the rate of whole chromosome changes but also the rate of other chromosomal changes, such as rearrangements, deletions, insertions, inversions and amplifications. Thus, the assay should be capable of determining the presence of both whole chromosome and segmental aneuploidies. Polyploid cells should be identified, and results should be recorded separately from those obtained for diploid cells. The fitness cost of CIN is much lower in polyploid cells, because reducing the copy number of a particular chromosome from 4 to 3 would be expected to have only small effects on the relative fitness of a cell [6]. Therefore, tetraploidization could be an effective strategy by which cancer cells could reduce the cost of CIN. Tetra- and triploid cells might therefore be more prone to chromosomal changes, which should be considered in determining the presence and degree of CIN. Appropriate statistical means should be used to establish if the rate of chromosomal changes in a test population differs significantly from a reference population. Concluding remarks Many published studies have assessed aneuploidy and polyploidy and equated these observations with 67
5 chromosomal instability (CIN). However, conclusive evidence for an increased rate of instability can only be achieved by specialized technologies capable of measuring cell-to-cell variability, and the description of such results should contain several parameters as outlined above. Because of frequently used yet insufficient technologies, the existence of CIN in early tumor stages remains elusive [6,7]. Further experimental developments are needed to accurately assess CIN in cell populations. CIN has been formally shown only for the gain or loss of whole or large portions of chromosomes in cancers. There is no assay at present that can reliably measure the rate of other chromosomal changes (e.g. deletions, insertions, inversions and amplifications). However, available cytogenetic data indicate that these latter changes are at least as common as losses or gains of whole chromosomes (see the Mitelman Database of Chromosome Aberrations in Cancer; cgap.nci.nih.gov/chromosomes/mitelman). It is essential for future research to discern if such changes reflect underlying CIN, which is probably the result of mechanisms other than disturbance of the chromosome segregation machinery, as is the case for whole chromosome instability [10,11]. Further refinements in single cell array-cgh [42,43] might enable researches to address this question. Future research and a more careful assessment of CIN should help refine our knowledge about its timing in tumorigenesis and to establish the exact role of CIN in tumor initiation and progression. Acknowledgements Work in our laboratory is supported by the European Commission (DISMAL project, contract no. LSHC-CT ). A.C.O. is funded by the PhD-Program Molecular Medicine of the Medical University of Graz. References 1 Sjöblom, T. et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314, Loeb, L.A. (2001) A mutator phenotype in cancer. Cancer Res. 61, Artandi, S.E. et al. (2000) Telomere dysfunction promotes nonreciprocal translocations and epithelial cancers in mice. Nature 406, Duesberg, P. et al. (2000) Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy. Proc. Natl. Acad. Sci. U. S. A. 97, Beckman, R.A. and Loeb, L.A. (2005) Genetic instability in cancer: theory and experiment. Semin. Cancer Biol. 15, Rajagopalan, H. et al. (2003) The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer 3, Sieber, O.M. et al. (2003) Genomic instability the engine of tumorigenesis? Nat. Rev. Cancer 3, Lengauer, C. et al. (1997) Genetic instability in colorectal cancers. Nature 386, Lengauer, C. et al. (1998) Genetic instabilities in human cancers. Nature 396, Cahill, D.P. et al. (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392, Michel, L.S. et al. (2001) MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409, Jallepalli, P.V. et al. (2001) Securin is required for chromosomal stability in human cells. Cell 105, Geigl, J.B. et al. (2004) Analysis of gene expression patterns and chromosomal changes associated with aging. Cancer Res. 64, Pfleghaar, K. et al. (2005) Securin is not required for chromosomal stability in human cells. PLoS Biol. 3, e Rajagopalan, H. et al. (2004) Inactivation of hcdc4 can cause chromosomal instability. Nature 428, McEvoy, J.D. et al. (2007) Constitutive turnover of cyclin E by Cul3 maintains quiescence. Mol. Cell. Biol. 27, Weaver, B.A. and Cleveland, D.W. (2006) Does aneuploidy cause cancer? Curr. Opin. Cell Biol. 18, Baker, D.J. et al. (2005) The mitotic checkpoint in cancer and aging: what have mice taught us? Curr. Opin. Cell Biol. 17, Finkel, T. et al. (2007) The common biology of cancer and ageing. Nature 448, Abdel-Rahman, W.M. et al. (2001) Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc. Natl. Acad. Sci. U. S. A. 98, Lynch, H.T. and de la Chapelle, A. (2003) Hereditary colorectal cancer. N. Engl. J. Med. 348, Rajagopalan, H. et al. (2002) Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418, Weisenberger, D.J. et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38, Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell 61, Kinzler, K.W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, Hawkins, N.J. et al. (2001) Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer. Br. J. Cancer 84, Baker, D.J. et al. (2004) BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat. Genet. 36, Baker, D.J. et al. (2006) Early aging-associated phenotypes in Bub3/ Rae1 haploinsufficient mice. J. Cell Biol. 172, Sotillo, R. et al. (2007) Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, Weaver, B.A. et al. (2007) Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11, Hanks, S. et al. (2004) Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat. Genet. 36, Antonarakis, S.E. et al. (2004) Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat. Rev. Genet. 5, Hitzler, J.K. and Zipursky, A. (2005) Origins of leukaemia in children with Down syndrome. Nat. Rev. Cancer 5, Satgé, D. et al. (1998) A tumor profile in Down syndrome. Am. J. Med. Genet. 78, Yang, Q. et al. (2002) Mortality associated with Down s syndrome in the U. S. A. from 1983 to 1997: a population-based study. Lancet 359, Speicher, M.R. and Carter, N.P. (2005) The new cytogenetics: blurring the boundaries with molecular biology. Nat. Rev. Genet. 6, Jass, J.R. (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50, Hampel, H. et al. (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 66, Southey, M.C. et al. (2005) Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J. Clin. Oncol. 23, Rowan, A. et al. (2005) Refining molecular analysis in the pathways of colorectal carcinogenesis. Clin. Gastroenterol. Hepatol. 3, Weber, J.C. et al. (2007) Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes. Int. J. Cancer 120, Le Caignec, C. et al. (2006) Single-cell chromosomal imbalances detection by array CGH. Nucleic Acids Res. 34, e68 68
6 43 Fiegler, H. et al. (2007) High resolution array-cgh analysis of single cells. Nucleic Acids Res. 35, e15 44 Ballif, B.C. et al. (2006) Detection of low-level mosaicism by array-cgh in routine diagnostic specimens. Am. J. Med. Genet. 140, Vogelstein, B. and Kinzler, K.W. (1999) Digital PCR. Proc. Natl. Acad. Sci. U. S. A. 96, Shih, I.M. et al. (2001) Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res. 61, Garraway, L.A. et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, Five things you might not know about Elsevier 1. Elsevier is a founder member of the WHO s HINARI and AGORA initiatives, which enable the world s poorest countries to gain free access to scientific literature. More than 1000 journals, including the Trends and Current Opinion collections and Drug Discovery Today, are now available free of charge or at significantly reduced prices. 2. The online archive of Elsevier s premier Cell Press journal collection became freely available in January Free access to the recent archive, including Cell, Neuron, Immunity and Current Biology, is available on ScienceDirect and the Cell Press journal sites 12 months after articles are first published. 3. Have you contributed to an Elsevier journal, book or series? Did you know that all our authors are entitled to a 30% discount on books and stand-alone CDs when ordered directly from us? For more information, call our sales offices: (USA) or (Canada, South and Central America) or +44 (0) (all other countries) 4. Elsevier has a long tradition of liberal copyright policies and for many years has permitted both the posting of preprints on public servers and the posting of final articles on internal servers. Now, Elsevier has extended its author posting policy to allow authors to post the final text version of their articles free of charge on their personal websites and institutional repositories or websites. 5. The Elsevier Foundation is a knowledge-centered foundation that makes grants and contributions throughout the world. A reflection of our culturally rich global organization, the Foundation has, for example, funded the setting up of a video library to educate for children in Philadelphia, provided storybooks to children in Cape Town, sponsored the creation of the Stanley L. Robbins Visiting Professorship at Brigham and Women s Hospital, and given funding to the 3rd International Conference on Children s Health and the Environment. 69
Development of Carcinoma Pathways
The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019
More informationGenomic Instability. Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute. RPN-530 Oncology for Scientist-I October 18, 2016
Genomic Instability Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute RPN-530 Oncology for Scientist-I October 18, 2016 Previous lecturers supplying slides/notes/inspiration Daniel
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationMolecular mechanisms of human carcinogenesis
Cancer: Cell Structures, Carcinogens and Genomic Instability Edited by Leon P. Bignold 2006 Birkhäuser Verlag/Switzerland 321 Molecular mechanisms of human carcinogenesis William B. Coleman 1 and Gregory
More informationColon Cancer and Hereditary Cancer Syndromes
Colon Cancer and Hereditary Cancer Syndromes Gisela Keller Institute of Pathology Technische Universität München gisela.keller@lrz.tum.de Colon Cancer and Hereditary Cancer Syndromes epidemiology models
More informationSerrated Polyps and a Classification of Colorectal Cancer
Serrated Polyps and a Classification of Colorectal Cancer Ian Chandler June 2011 Structure Serrated polyps and cancer Molecular biology The Jass classification The familiar but oversimplified Vogelsteingram
More informationAnatomic Molecular Pathology: An Emerging Field
Anatomic Molecular Pathology: An Emerging Field Antonia R. Sepulveda M.D., Ph.D. University of Pennsylvania asepu@mail.med.upenn.edu 2008 ASIP Annual Meeting Anatomic pathology (U.S.) is a medical specialty
More informationRole of FISH in Hematological Cancers
Role of FISH in Hematological Cancers Thomas S.K. Wan PhD,FRCPath,FFSc(RCPA) Honorary Professor, Department of Pathology & Clinical Biochemistry, Queen Mary Hospital, University of Hong Kong. e-mail: wantsk@hku.hk
More informationB Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696
Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591
More informationStructural Variation and Medical Genomics
Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationThe Role of ploidy in neuroblastoma. Michael D. Hogarty, MD Division of Oncology Children s Hospital of Philadelphia
The Role of ploidy in neuroblastoma Reprinted from NB Journal Summer Issue 2003 Children s Neuroblastoma Cancer Foundation Michael D. Hogarty, MD Division of Oncology Children s Hospital of Philadelphia
More informationA. Incorrect! All the cells have the same set of genes. (D)Because different types of cells have different types of transcriptional factors.
Genetics - Problem Drill 21: Cytogenetics and Chromosomal Mutation No. 1 of 10 1. Why do some cells express one set of genes while other cells express a different set of genes during development? (A) Because
More informationMohammed El-Khateeb. Tumor Genetics. MGL-12 May 13 th Chapter 22 slide 1 台大農藝系遺傳學
Mohammed El-Khateeb Tumor Genetics MGL-12 May 13 th 2014 台大農藝系遺傳學 601 20000 Chapter 22 slide 1 Cancer Genetics Types of Genetic Alterations in Cancer Evidence that Mutations Cause Cancer Multistage Model
More informationPolicy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014
Medical Policy Genetic Testing for Colorectal Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: October
More informationCanadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010
Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination May 4, 2010 Examination Length = 3 hours Total Marks = 100 (7 questions) Total Pages = 8 (including cover sheet and 2 pages of prints)
More informationCYTOGENETICS Dr. Mary Ann Perle
CYTOGENETICS Dr. Mary Ann Perle I) Mitosis and metaphase chromosomes A) Chromosomes are most fully condensed and clearly distinguishable during mitosis. B) Mitosis (M phase) takes 1 to 2 hrs and is divided
More informationAn Overview of Cytogenetics. Bridget Herschap, M.D. 9/23/2013
An Overview of Cytogenetics Bridget Herschap, M.D. 9/23/2013 Objectives } History and Introduction of Cytogenetics } Overview of Current Techniques } Common cytogenetic tests and their clinical application
More informationAsingle inherited mutant gene may be enough to
396 Cancer Inheritance STEVEN A. FRANK Asingle inherited mutant gene may be enough to cause a very high cancer risk. Single-mutation cases have provided much insight into the genetic basis of carcinogenesis,
More informationMRC-Holland MLPA. Description version 29;
SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,
More informationUnderstanding the Human Karyotype Colleen Jackson Cook, Ph.D.
Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.
More informationChromosome Abnormalities
Chromosome Abnormalities Chromosomal abnormalities vs. molecular mutations Simply a matter of size Chromosomal abnormalities are big errors Two types of abnormalities 1. Constitutional problem present
More informationMohammed El-Khateeb. Tumor Genetics. MGL-12 July 21 st 2013 台大農藝系遺傳學 Chapter 22 slide 1
Mohammed El-Khateeb Tumor Genetics MGL-12 July 21 st 2013 台大農藝系遺傳學 601 20000 Chapter 22 slide 1 Cellular Basis of Cancer Cancer is a collection of diseases characterized by abnormal and uncontrolled growth
More informationChromothripsis: A New Mechanism For Tumorigenesis? i Fellow s Conference Cheryl Carlson 6/10/2011
Chromothripsis: A New Mechanism For Tumorigenesis? i Fellow s Conference Cheryl Carlson 6/10/2011 Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development Cell 144,
More informationChapt 15: Molecular Genetics of Cell Cycle and Cancer
Chapt 15: Molecular Genetics of Cell Cycle and Cancer Student Learning Outcomes: Describe the cell cycle: steps taken by a cell to duplicate itself = cell division; Interphase (G1, S and G2), Mitosis.
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/22278 holds various files of this Leiden University dissertation. Author: Cunha Carvalho de Miranda, Noel Filipe da Title: Mismatch repair and MUTYH deficient
More informationPrecision Genetic Testing in Cancer Treatment and Prognosis
Precision Genetic Testing in Cancer Treatment and Prognosis Deborah Cragun, PhD, MS, CGC Genetic Counseling Graduate Program Director University of South Florida Case #1 Diana is a 47 year old cancer patient
More informationThe diagnostic and prognostic value of genetic aberrations in resectable distal bile duct cancer Rijken, A.M.
UvA-DARE (Digital Academic Repository) The diagnostic and prognostic value of genetic aberrations in resectable distal bile duct cancer Rijken, A.M. Link to publication Citation for published version (APA):
More informationColonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern
Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit
More informationIntroduction to Genetics
Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist
More informationThe mutations that drive cancer. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge
The mutations that drive cancer Paul Edwards Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge Previously on Cancer... hereditary predisposition Normal Cell Slightly
More informationAmerican Society of Cytopathology Core Curriculum in Molecular Biology
American Society of Cytopathology Core Curriculum in Molecular Biology American Society of Cytopathology Core Curriculum in Molecular Biology Chapter 1 Molecular Basis of Cancer Molecular Oncology Keisha
More informationLESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2
For a complete list of defined terms, see the Glossary. Transformation the process by which a cell acquires characteristics of a tumor cell. LESSON 3.2 WORKBOOK How do normal cells become cancer cells?
More informationHST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007
MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationoncogenes-and- tumour-suppressor-genes)
Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging
More informationYes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.
Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is
More informationComputational Systems Biology: Biology X
Bud Mishra Room 1002, 715 Broadway, Courant Institute, NYU, New York, USA L#4:(October-0-4-2010) Cancer and Signals 1 2 1 2 Evidence in Favor Somatic mutations, Aneuploidy, Copy-number changes and LOH
More informationAssociation for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology
Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology 9650 Rockville Pike, Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7990 Email:
More informationBeyond the APC era Alternative pathways to CRC. Jeremy R Jass McGill University
Beyond the APC era Alternative pathways to CRC Jeremy R Jass McGill University Outline Limitations of APC model KRAS and serrated polyps CRC and CpG island methylation Serrated pathway to CRC Fusion pathways
More informationGenetic Testing for Lynch Syndrome
Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post-test genetic counseling is
More informationChapter 15 Notes 15.1: Mendelian inheritance chromosome theory of inheritance wild type 15.2: Sex-linked genes
Chapter 15 Notes The Chromosomal Basis of Inheritance Mendel s hereditary factors were genes, though this wasn t known at the time Now we know that genes are located on The location of a particular gene
More informationCancer and sornat ic evolution
Chapter 1 Cancer and sornat ic evolution 1.1 What is cancer? The development and healthy life of a human being requires the cooperation of more than ten million cells for the good of the organism. This
More informationAn adult human has somewhere around one hundred trillion (10 14 ) cells
2/22/10 Cancer genetics Inside cancer web site http://www.insidecancer.org/ National Cancer Institute http://www.cancer.gov/cancerinfo/ An adult human has somewhere around one hundred trillion (10 14 )
More informationGENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome
GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By HENRY T. LYNCH, M.D. 1 Could this be hereditary Colon Cancer 4 Creighton University School of Medicine Omaha, Nebraska Magnitude of the Problem Annual
More informationPrior Authorization. Additional Information:
Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationCHROMOSOMAL MICROARRAY (CGH+SNP)
Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due
More informationThe Chromosomal Basis Of Inheritance
The Chromosomal Basis Of Inheritance Chapter 15 Objectives Explain the chromosomal theory of inheritance and its discovery. Explain why sex-linked diseases are more common in human males than females.
More informationChapter 8. The Cellular Basis of Reproduction and Inheritance. Lecture by Mary C. Colavito
Chapter 8 The Cellular Basis of Reproduction and Inheritance PowerPoint Lectures for Biology: Concepts & Connections, Sixth Edition Campbell, Reece, Taylor, Simon, and Dickey Copyright 2009 Pearson Education,
More informationGeneral Session 7: Controversies in Screening and Surveillance in Colorectal Cancer
General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer Complexities of Pathological Assessment: Serrated Polyps/Adenomas Carolyn Compton, MD, PhD Professor of Life Sciences,
More informationChapter 10 Chromosomes and Cell Reproduction
Chapter 10 Chromosomes and Cell Reproduction Chromosomes Organisms grow by dividing of cells Binary Fission form of asexual reproduction that produces identical offspring (Bacteria) Eukaryotes have two
More informationManagement of higher risk of colorectal cancer. Huw Thomas
Management of higher risk of colorectal cancer Huw Thomas Colorectal Cancer 41,000 new cases pa in UK 16,000 deaths pa 60% 5 year survival Adenoma-carcinoma sequence (Morson) Survival vs stage (Dukes)
More informationThe Chromosomal Basis of Inheritance
The Chromosomal Basis of Inheritance Factors and Genes Mendel s model of inheritance was based on the idea of factors that were independently assorted and segregated into gametes We now know that these
More informationSignificance of Chromosome Changes in Hematological Disorders and Solid Tumors
Significance of Chromosome Changes in Hematological Disorders and Solid Tumors Size of Components of Human Genome Size of haploid genome! Estimated genetic constitution! Size of average chromosome
More information2003 Landes Bioscience. Not for distribution.
[Cancer Biology & Therapy 1:6, 685-692, November/December 2002]; 2002 Landes Bioscience Research Paper Dynamics of Genetic Instability in Sporadic and Familial Colorectal Cancer Natalia L. Komarova 1,2
More informationSignificance of Chromosome Changes in Hematological Disorders and Solid Tumors
Significance of Chromosome Changes in Hematological Disorders and Solid Tumors Size of Components of Human Genome Size of haploid genome 3.3 X 10 9 DNA basepairs Estimated genetic constitution 30,000
More informationRegulators of Cell Cycle Progression
Regulators of Cell Cycle Progression Studies of Cdk s and cyclins in genetically modified mice reveal a high level of plasticity, allowing different cyclins and Cdk s to compensate for the loss of one
More informationCELL CYCLE REGULATION AND CANCER. Cellular Reproduction II
CELL CYCLE REGULATION AND CANCER Cellular Reproduction II THE CELL CYCLE Interphase G1- gap phase 1- cell grows and develops S- DNA synthesis phase- cell replicates each chromosome G2- gap phase 2- cell
More informationExploring aneuploidy: the significance of chromosomal imbalance review series Sarah J. Pfau & Angelika Amon +
Chromosomal instability and aneuploidy in cancer: from yeast to man Exploring aneuploidy: the significance of chromosomal imbalance series Sarah J. Pfau & Angelika Amon + David H. Koch Institute for Integrative
More informationGenomic instability. Amin Mahpour
Genomic instability Amin Mahpour 1 Some questions to ponder What is Genomic instability? What factors contribute to the genomic integrity? How we identify these aberrations? 2 PART I: MOLECULAR BIOLOGY
More informationCANCER GENETICS PROVIDER SURVEY
Dear Participant, Previously you agreed to participate in an evaluation of an education program we developed for primary care providers on the topic of cancer genetics. This is an IRB-approved, CDCfunded
More informationMitosis. An Introduction to Genetics. An Introduction to Cell Division
Mitosis An Introduction to Genetics An Introduction to Cell Division DNA is Packaged in Chromosomes Cell Cycle Mitosis and Cytokinesis Variations in Cell Division Cell Division and Cancer An Introduction
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationLYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)!
LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)! Kathryn Singh, MPH, MS, LCGC Associate Clinical Professor Assistant Director, Graduate Program in Genetic Counseling Division of Genetic and Genomic
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationMRC-Holland MLPA. Description version 06; 23 December 2016
SALSA MLPA probemix P417-B2 BAP1 Lot B2-1216. As compared to version B1 (lot B1-0215), two reference probes have been added and two target probes have a minor change in length. The BAP1 (BRCA1 associated
More informationCytogenetics 101: Clinical Research and Molecular Genetic Technologies
Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these
More informationCellular Reproduction Chapter 8
Cellular Reproduction Chapter 8 1. Importance of Cell Division 2. Eukaryotic Cell Cycle 3. Eukaryotic Chromosomes 4. Mitosis 5. Cytokinesis in animal and plant cells 6. Sexual Iife cycle 7. Meiosis 8.
More informationCancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous
Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors
More informationPart II The Cell Cell Division, Chapter 2 Outline of class notes
Part II The Cell Cell Division, Chapter 2 Outline of class notes 1 Cellular Division Overview Types of Cell Division Chromosomal Number The Cell Cycle Mitoses Cancer Cells In Vitro Fertilization Infertility
More informationTransform genomic data into real-life results
CLINICAL SUMMARY Transform genomic data into real-life results Biomarker testing and targeted therapies can drive improved outcomes in clinical practice New FDA-Approved Broad Companion Diagnostic for
More informationBASIC CONCEPTS OF CANCER: GENOMIC DETERMINATION
BASIC CONCEPTS OF CANCER: GENOMIC DETERMINATION Edith Oláh Corresponding author s address: Prof. Edith Olah, Ph.D., D.Sc. Department of Molecular Genetics, National Institute of Oncology, H-1525 Budapest,
More informationThe Cell Cycle. Chapter 10
The Cell Cycle Chapter 10 Why Do Cells Divide? Unicellular 1. Reproduction Multicellular 1. Grow 2. Repair 3. Development/reproduction Types of Division Prokaryotic cells Binary fission = asexual reproduction
More informationCancer genetics
Cancer genetics General information about tumorogenesis. Cancer induced by viruses. The role of somatic mutations in cancer production. Oncogenes and Tumor Suppressor Genes (TSG). Hereditary cancer. 1
More informationNeoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath
Neoplasia 18 lecture 6 Dr Heyam Awad MD, FRCPath ILOS 1. understand the role of TGF beta, contact inhibition and APC in tumorigenesis. 2. implement the above knowledge in understanding histopathology reports.
More informationThe questions below refer to the following terms. Each term may be used once, more than once, or not at all.
The questions below refer to the following terms. Each term may be used once, more than once, or not at all. a) telophase b) anaphase c) prometaphase d) metaphase e) prophase 1) DNA begins to coil and
More informationTITLE: Identification of Chromosomes Alterations in Primary Breast Cancer Using Premature Chromosome Condensation
AD Award Number: DAMD17-99-1-9237 TITLE: Identification of Chromosomes Alterations in Primary Breast Cancer Using Premature Chromosome Condensation PRINCIPAL INVESTIGATOR: Constance A. Griffin, M.D. CONTRACTING
More informationMultiple Fibroadenomas Harboring Carcinoma in Situ in a Woman with a Familty History of Breast/ Ovarian Cancer
Multiple Fibroadenomas Harboring Carcinoma in Situ in a Woman with a Familty History of Breast/ Ovarian Cancer A Kuijper SS Preisler-Adams FD Rahusen JJP Gille E van der Wall PJ van Diest J Clin Pathol
More informationChromosome Structure & Recombination
Chromosome Structure & Recombination (CHAPTER 8- Brooker Text) April 4 & 9, 2007 BIO 184 Dr. Tom Peavy Genetic variation refers to differences between members of the same species or those of different
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationmeiosis asexual reproduction CHAPTER 9 & 10 The Cell Cycle, Meiosis & Sexual Life Cycles Sexual reproduction mitosis
meiosis asexual reproduction CHAPTER 9 & 10 The Cell Cycle, Meiosis & Sexual Sexual reproduction Life Cycles mitosis Chromosomes Consists of a long DNA molecule (represents thousands of genes) Also consists
More informationreview Losing balance: the origin and impact of aneuploidy in cancer review
review Losing balance: the origin and impact of aneuploidy in cancer Exploring aneuploidy: the significance of chromosomal imbalance review series Andrew J. Holland + & Don W. Cleveland ++ Ludwig Institute
More informationBreaking Up is Hard to Do (At Least in Eukaryotes) Mitosis
Breaking Up is Hard to Do (At Least in Eukaryotes) Mitosis Chromosomes Chromosomes were first observed by the German embryologist Walther Fleming in 1882. Chromosome number varies among organisms most
More informationUpdated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors
Q: How is the strength of recommendation determined in the new molecular testing guideline? A: The strength of recommendation is determined by the strength of the available data (evidence). Strong Recommendation:
More informationCytogenetics Technologies, Companies & Markets
Cytogenetics Technologies, Companies & Markets By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland November 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R A P H Y Professor
More informationLynch Syndrome Screening for Endometrial Cancer: Basic Concepts 1/16/2017
1 Hi, my name is Sarah Kerr. I m a pathologist at Mayo Clinic, where I participate in our high volume Lynch syndrome tumor testing practice. Today I hope to cover some of the basics needed to understand
More informationGenetic testing all you need to know
Genetic testing all you need to know Sue Clark Consultant Colorectal Surgeon, St Mark s Hospital, London, UK. Colorectal cancer Familial 33% Polyposis syndromes
More informationDOES THE BRCAX GENE EXIST? FUTURE OUTLOOK
CHAPTER 6 DOES THE BRCAX GENE EXIST? FUTURE OUTLOOK Genetic research aimed at the identification of new breast cancer susceptibility genes is at an interesting crossroad. On the one hand, the existence
More informationCopyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Chapter 9 MITOSIS
Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Chapter 9 MITOSIS Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 9.1
More information609G: Concepts of Cancer Genetics and Treatments (3 credits)
Master of Chemical and Life Sciences Program College of Computer, Mathematical, and Natural Sciences 609G: Concepts of Cancer Genetics and Treatments (3 credits) Text books: Principles of Cancer Genetics,
More informationInformation for You and Your Family
Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the
More informationReporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota
Reporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota Reporting cytogenetics What is it? Terminology Clinical value What details are important Diagnostic Tools for Leukemia
More informationColorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.
Colonic Neoplasia Remotti Colorectal adenocarcinoma leading cancer in developed countries In US, annual incidence of colorectal adenocarcinoma 150,000. In US, annual deaths due to colorectal adenocarcinoma
More informationNOTES- CHAPTER 6 CHROMOSOMES AND CELL REPRODUCTION
NOTES- CHAPTER 6 CHROMOSOMES AND CELL REPRODUCTION Section I Chromosomes Formation of New Cells by Cell Division New cells are formed when old cells divide. 1. Cell division is the same as cell reproduction.
More informationIntroduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.
Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)
More informationBIOLOGY - CLUTCH CH.15 - CHROMOSOMAL THEORY OF INHERITANCE
!! www.clutchprep.com Chromosomal theory of inheritance: chromosomes are the carriers of genetic material. Independent Assortment alleles for different characters sort independently of each other during
More informationReview The Consequences of Chromosome Segregation Errors in Mitosis and Meiosis
Review The Consequences of Chromosome Segregation Errors in Mitosis and Meiosis Tamara Potapova 1 and Gary J. Gorbsky 2, * 1 Stowers Institute for Medical Research, Kansas City, MO 64110, USA 2 Cell Cycle
More informationSALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407
SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407 The Mismatch Repair (MMR) system is critical for the maintenance of genomic stability. MMR increases the fidelity of DNA
More information